# OnCo record azur-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/azur-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "azur-1", "NCT05723562" ;
  schema:name "AZUR-1"@en ;
  schema:description "AZUR-1 is the registrational trial of the 'no surgery, no radiation, no chemo' approach for mismatch-repair-deficient rectal cancer, built on the MSK study where every patient had a complete response."@en ;
  schema:url <https://onco.cc/trials/azur-1/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05723562>, <https://www.gsk.com/en-gb/media/press-releases/jemperli-dostarlimab-accepted-for-priority-review-by-the-us-fda/> ;
  onco:status "positive" ;
  onco:phase "2" ;
  schema:startDate "2023-04-03" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/msi-high-colorectal/>, <https://onco.cc/cancers/rectal-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/dostarlimab/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/terms/clinical-complete-response/> ;
  onco:people <https://onco.cc/people/andrea-cercek/> .
